Imagine a hospital intensive care unit (ICU). Wires, screens, and the constant, piercing sound of alarms. But what if many of those alarms don't actually require immediate action? What if they're just noise, distracting clinicians from truly critical situations? This challenge is at the heart of groundbreaking research by Dr. Akira Poncette and his team.

Monisola Jayeoba, a PhD student in the Technology and Social Behavior Program at Northwestern University, recently published a significant paper in the Journal of Medical Internet Research. The article, titled "Low-Burden Electronic Health Record Strategies for Engaging Oncologists in Digital Health Behavior Change Interventions," delves into how oncologists prefer to be involved when their patients participate in digital health behavior change interventions.

Imagine a world where your healthcare information flows seamlessly between your doctor, specialists, and even your pharmacy. This isn't a futuristic dream, but a goal that Fast Healthcare Interoperability Resources (FHIR) aims to make a reality. FHIR provides a crucial set of standards for software companies developing health information systems, enabling these systems to "speak to each other" with unprecedented ease. The widespread adoption of FHIR promises to revolutionize healthcare by promoting data sharing, improving accessibility for patients and providers, and ultimately enhancing the quality of care.

It's an exciting time here at JMIR Publications, and we're thrilled to share some truly remarkable news from the recently released Journal Citation Reports 2025 from Clarivate. This year, a phenomenal 21 JMIR Publications journals now boast a Journal Impact Factor, with several experiencing significant year-over-year increases and achieving top-ranked distinctions within their respective disciplines. 

Professor Gemma Sharp, a Clinical Psychologist based in Melbourne, Australia, and the Founding Director of the International Consortium for Research in Eating Disorders, recently led the publication of a significant paper in the Journal of Medical Internet Research. The article, titled "The Effectiveness of a Chatbot Single-Session Intervention for People on Waitlists for Eating Disorder Treatment: Randomized Controlled Trial," explores a novel approach to supporting individuals awaiting eating disorder treatment.

The landscape of healthcare is evolving, and at the forefront of this transformation is the powerful concept of patient engagement. "Patient-Powered Progress: Revolutionary Digital Strategies for Optimal Patient Engagement and Healthcare Delivery," a groundbreaking conference, is taking place from June 25-27, 2025, at Harvard University.

(Toronto, June 13, 2025) – JMIR Publications is delighted to announce its outstanding results in the latest Scopus CiteScore rankings. This year, 26 of our journals have been awarded a CiteScore, a reflection of the high-quality, impactful research published across our portfolio. These results reinforce our commitment to advancing the digital health landscape.

A groundbreaking initiative from the University of Chicago's Section of General Internal Medicine is shedding light on a novel approach to chronic kidney disease (CKD) education. Akilah King, a project manager from the team, recently shared insights into her published protocol for a randomized controlled trial: " Interactive Computer Adaptive Chronic Kidney Disease Education for Hospitalized African American Patients," featured in JMIR Research Protocols.

The American Psychiatric Association (APA) 2025 Annual Meeting in Los Angeles was an inspiring and insightful experience for the JMIR Publications team. We had the privilege of connecting with countless dedicated professionals, from seasoned researchers and clinicians to enthusiastic students, all united by a common goal: advancing mental health care.

Botulinum toxin injections have become a cornerstone of aesthetic medicine, offering a popular solution for reducing wrinkles and achieving a more youthful appearance. However, as more patients seek these treatments, and often start at a younger age, a growing concern has emerged: botulinum toxin nonresponse.